{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:38:20Z","timestamp":1773715100335,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ijpharm.2015.12.024","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T14:19:19Z","timestamp":1450361959000},"page":"371-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig ( Sus scrofa domesticus )"],"prefix":"10.1016","volume":"500","author":[{"given":"M.J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tomlins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hubble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2015.12.024_bib0005","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S1751-9918(10)60005-8","article-title":"Basal insulins: pharmacological properties and patient perspectives","volume":"4","author":"Abrahamson","year":"2010","journal-title":"Prim. Care Diabetes"},{"issue":"Suppl","key":"10.1016\/j.ijpharm.2015.12.024_bib0010","first-page":"S003","article-title":"Standards of medical care in diabetes\u20142015: summary of revisions","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0015","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1517\/17425247.2015.1074174","article-title":"Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas","volume":"12","author":"Ang","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ecl.2010.05.005","article-title":"Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems","volume":"39","author":"Aye","year":"2010","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0025","first-page":"S13","article-title":"Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence","volume":"111","author":"Barag","year":"2011","journal-title":"J. Am. Osteopath. Assoc."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.beem.2015.03.001","article-title":"Closed loop insulin delivery in diabetes","volume":"29","author":"Battelino","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"Suppl. 4","key":"10.1016\/j.ijpharm.2015.12.024_bib0035","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/S1262-3636(12)71538-0","article-title":"Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE","volume":"38","author":"Benhamou","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0040","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.2337\/db13-1649","article-title":"Glucose sensing in the peritoneal space offers faster kinetics than sensing in the subcutaneous space","volume":"63","author":"Burnett","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0045","first-page":"1","article-title":"Moving toward the ideal insulin for insulin pumps","author":"Cengiz","year":"2015","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0050","article-title":"Impact of frequent and persistent use of continuous glucose monitoring (CGM) on hypoglycemia fear, frequency of emergency medical treatment, and SMBG frequency after one year","author":"Chamberlain","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/dia.2014.0229","article-title":"In vivo performance and biocompatibility of a subcutaneous implant for real-time glucose-responsive insulin delivery","volume":"17","author":"Chu","year":"2015","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diabres.2011.01.002","article-title":"Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes","volume":"92","author":"Cukierman-Yaffe","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0065","series-title":"State of the Nation","author":"Diabetes UK","year":"2012"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1211\/jpp.60.1.0001","article-title":"The future of open and closed-loop insulin delivery for diabetes mellitus","volume":"60","author":"Farmer","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0075","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cca.2011.10.012","article-title":"Accuracy of a portable glucose meter and of a continuous glucose monitoring device used at home by patients with type 1 diabetes","volume":"413","author":"Francescato","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diabres.2009.11.014","article-title":"Time lag characterization of two continuous glucose monitoring systems","volume":"87","author":"Garg","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial","volume":"185","author":"Haidar","year":"2013","journal-title":"CMAJ"},{"issue":"Suppl. 4","key":"10.1016\/j.ijpharm.2015.12.024_bib0090","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S1262-3636(11)70964-8","article-title":"External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives","volume":"37","author":"Hanaire","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0095","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(09)61998-X","article-title":"Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial","volume":"375","author":"Hovorka","year":"2010","journal-title":"The Lancet"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0100","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-15-321","article-title":"Effect of guided self-determination youth intervention integrated into outpatient visits versus treatment as usual on glycemic control and life skills: a randomized clinical trial in adolescents with type 1 diabetes","volume":"15","author":"Husted","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0105","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1021\/acs.iecr.5b01237","article-title":"Design and evaluation of a robust PID controller for a fully implantable artificial pancreas","volume":"54","author":"Huyett","year":"2015","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pcd.2010.11.001","article-title":"Deus ex machina: the use of technology in type 1 diabetes","volume":"5","author":"Kerr","year":"2011","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0115","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpeds.2008.11.047","article-title":"Continuous glucose monitoring study does not demonstrate benefit in children and adolescents","volume":"154","author":"Klonoff","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0120","first-page":"159","article-title":"Closed-loop insulin delivery: towards improved diabetes care","volume":"13","author":"Kumareswaran","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0125","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1089\/dia.2012.0109","article-title":"Carbohydrate-to-insulin ratio is estimated from 300 to 400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump","volume":"14","author":"Kuroda","year":"2012","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ilar.45.3.303","article-title":"Use of the Gottingen minipig as a model of diabetes: with special focus on type 1 diabetes research","volume":"45","author":"Larsen","year":"2004","journal-title":"ILAR J."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/1995-705X.151084","article-title":"Tight glycemic control and cardiovascular effects in type 2 diabetic patients","volume":"15","author":"Moodahadu","year":"2014","journal-title":"Heart Views"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0140","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (UK), 2015. doi: NBK315806 [bookaccession]."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.diabet.2011.03.001","article-title":"Current insulin therapy in patients with type 2 diabetes: results of the ADHOC survey in France","volume":"37","author":"Penfornis","year":"2011","journal-title":"Diabetes Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ijpharm.2015.12.024_bib0150","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S1751-9918(10)60004-6","article-title":"Addressing barriers to initiation of insulin in patients with type 2 diabetes","volume":"4","author":"Peyrot","year":"2010","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0155","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/dc14-1855","article-title":"Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives","volume":"38","author":"Pickup","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/193229680800200429","article-title":"Insulin delivery route for the artificial pancreas: subcutaneous, intraperitoneal, or intravenous? Pros and Cons","volume":"2","author":"Renard","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"issue":"Suppl. 4","key":"10.1016\/j.ijpharm.2015.12.024_bib0165","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/S1262-3636(11)70973-9","article-title":"Towards an artificial pancreas at home","volume":"37","author":"Renard","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0170","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/S0168-8227(06)70026-2","article-title":"Closed loop insulin delivery using implanted insulin pumps and sensors in type 1 diabetic patients","volume":"74","author":"Renard","year":"2006","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.diabres.2013.09.009","article-title":"Closed loop developments to improve glucose control at home","volume":"102","author":"Renard","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0180","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1314474","article-title":"Outpatient glycemic control with a bionic pancreas in type 1 diabetes","volume":"371","author":"Russell","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 4","key":"10.1016\/j.ijpharm.2015.12.024_bib0185","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1262-3636(11)70972-7","article-title":"Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors and implanted pumps","volume":"37","author":"Schaepelynck","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0190","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/1932296815590154","article-title":"Time delay of CGM sensors: relevance, causes, and countermeasures","volume":"9","author":"Schmelzeisen-Redeker","year":"2015","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0195","doi-asserted-by":"crossref","DOI":"10.1186\/1758-5996-4-7","article-title":"Goettingen minipigs (GMP): comparison of two different models for inducing diabetes","volume":"4","author":"Strauss","year":"2012","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0200","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1016\/j.biomaterials.2006.04.007","article-title":"The effect of degree of acrylic derivatisation on dextran and concanavalin A glucose-responsive materials for closed-loop insulin delivery","volume":"27","author":"Tanna","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0205","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.biomaterials.2005.08.011","article-title":"Glucose-responsive UV polymerised dextran-concanavalin A acrylic derivatised mixtures for closed-loop insulin delivery","volume":"27","author":"Tanna","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0210","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1002\/jps.22138","article-title":"In vivo study of a polymeric glucose sensitive insulin delivery system using a rat model","volume":"99","author":"Taylor","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0215","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1509351","article-title":"Home use of an artificial beta cell in type 1 diabetes","author":"Thabit","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ecl.2011.12.003","article-title":"Closed-loop insulin delivery in type 1 diabetes","volume":"41","author":"Thabit","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.ijpharm.2015.12.024_bib0225","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3109\/1061186X.2015.1055749","article-title":"Smart approaches to glucose-responsive drug delivery","volume":"23","author":"Webber","year":"2015","journal-title":"J. Drug Target."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315304245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517315304245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T15:59:14Z","timestamp":1653839954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517315304245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":45,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0378517315304245"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.12.024","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Closed-loop glycaemic control using an implantable artificial pancreas in diabetic domestic pig (Sus scrofa domesticus)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2015.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}